Media Releases

5 January, 2022

The Royal College of Pathologists of Australasia (RCPA) strongly recommends that PCR tests are now only available for: patients who are unwell; or, those who have been advised to do so by the Health Department.

At the present time, most laboratories have exceeded their testing capacity. This has happened for three reasons: the increased volume of testing; a change in how laboratories can now test due to a higher number of positive PCR results; and staff shortages.

29 December, 2021

The Royal College of Pathologists of Australasia (RCPA) continues to proudly support our pathology fellows and senior scientists wherever possible through our role in training, con-tinuing professional development, quality and professional standards, to help them to pro-vide the highest standards of pathology testing to all Australians.

18 November, 2021

This month, three new items will be added to the Medicare Benefits Schedule (MBS) following several applications by the Royal College of Pathologists of Australasia (RCPA) to the Medical Services Advisory Committee (MSAC). The items include genetic testing for certain blood cell cancers and for pregnancies with major fetal structural abnormalities, and diagnostic testing for neuromyelitis (NMO). It is expected that these additions will improve access to life changing pathology services for approximately 22-23,000 patients per year.

16 November, 2021

On Wednesday 10 November, to celebrate International Pathology Day (IPD) 2021, the Royal College of Pathologists of Australasia (RCPA) held an event to discuss the pathology milestones that have been reached with COVID-19 since IPD 2020. Hosted by the ABC’s Sophie Scott and watched by over 100 people online and in person, seven esteemed pathologists from the very heart of Australia’s response to the pandemic discussed: the future of vaccines; changes in our approach to the pandemic; updates in testing; and challenges in remote and rural communities.

10 August, 2021

Due to limitations in sensitivity, the Royal College of Pathologists of Australasia remains concerned over the uncontrolled use of rapid antigen tests (RATs) in Australia and New Zealand whilst the prevalence of SARS-CoV-2 remains generally low. However, the RCPA recognises that governments and public health authorities fighting localised outbreaks may need to use RATs for surveillance testing in defined circumstances, in addition to the more accurate mainstream molecular tests.

2 August, 2021

The Royal College of Pathologists of Australasia (RCPA) has announced the winner of its eighth annual media awards for excellence in journalism relating to pathology. The winner was decided during the RCPA’s annual Pathology Update Conference, Pathology Update 2021 – Re-Cracking the Code, which was held virtually last month.

23 July, 2021

As more real-world evidence surrounding rapid antigen tests comes to light, the Royal College of Pathologists of Australasia reaffirms its position against the widespread use of these tests in Australia and New Zealand, due to the limitations in their sensitivity. The RCPA strongly urges that careful consideration, further monitoring and evidence is required before considering the implementation of rapid antigen testing in both countries.

2 July, 2021

Professor Stuart Tangye, a speaker at the Royal College of Pathologists of Australasia’s (RCPA) annual conference, explains how next generation sequencing (NGS) for the diagnosis of primary immunodeficiencies (PID) is providing increased opportunities for precision or personalised medicine. This comes following the recent discovery of many new gene defects, with implications for many patients.

2 July, 2021

Pathology testing is a vital part of preventative healthcare such as screening tests, as well as for diagnosis and management of chronic diseases.

My Health Record lets healthcare providers and patients easily access this information, enabling continuity of care across the healthcare system and in the community.

2 July, 2021

The Royal College of Pathologists of Australasia (RCPA) is once again reminding the community to be tested for COVID-19. This follows new market research* by the RCPA, which reveals that 45% of respondents chose not to get tested, despite experiencing cold and flu like symptoms within the past six months.

Displaying results 1 - 10 of 75

Page last updated:

Copyright © 2022 RCPA. All rights reserved.